Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

18.42
+0.87004.96%
Post-market: 18.640.2200+1.19%19:50 EDT
Volume:7.07M
Turnover:130.69M
Market Cap:14.69B
PE:-16.48
High:18.83
Open:18.07
Low:17.97
Close:17.55
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:1.28
T/O Rate:4.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:23.33
PE(LYR):-12.76

Loading ...

Summit Therapeutics Faces Serious Going-Concern Risk as Cash Shortfall Threatens Operations

TIPRANKS
·
Jul 25

Summit Therapeutics Flags Going Concern Risk Over Cash Needs

Benzinga Earnings
·
Jul 24

U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor

Reuters
·
Jul 24

U.S. Stocks on the Move-tenet Healthcare, Intel, Verizon

Reuters
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Summit Therapeutics (SMMT) and Progyny (PGNY)

TIPRANKS
·
Jul 24

Summit Therapeutics Falls After Share Sale Plans, Q2 Report

Reuters
·
Jul 24

Piper Sandler Keeps Their Hold Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
Jul 24

Stock Track | Summit Therapeutics PLC Plunges 5.54% Intraday on Widening Non-GAAP Loss and $380 Million Stock Offering Plan

Stock Track
·
Jul 24

Summit Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 24

Summit Therapeutics Launches At-the-market Equity Program for up to $380 Million

Reuters
·
Jul 24

Stock Track | Summit Therapeutics Plunges 6% After-Hours as Non-GAAP Loss Widens on Surging Ivonescimab Development Costs

Stock Track
·
Jul 24

Summit Therapeutics says will need to raise additional capital

TIPRANKS
·
Jul 24

Summit Therapeutics - to Offer and Sell Common Stock up to $380 Mln Aggregate Through Sales Agent - SEC Filing

THOMSON REUTERS
·
Jul 24

Summit Therapeutics Q2 FY26 Net Loss Narrows to $215.7 Million

Reuters
·
Jul 24

Summit Therapeutics Q2 Net Income USD -215.7 Million

Reuters
·
Jul 24

Summit Therapeutics Q2 EPS USD -0.28

THOMSON REUTERS
·
Jul 24

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026

THOMSON REUTERS
·
Jul 24

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT), Molina Healthcare (MOH) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 23

European Car Market Stages Robust Recovery with Strongest Monthly Sales Gain in Nearly Three Years, Electric Vehicles Provide Critical Boost

Stock News
·
Jul 23

UK’s EV battery sector moves to industrial scale, but can it build a midstream?: Battery Cells & Systems Expo

Fastmarkets
·
Jul 23